WAYLAND, Mass., Feb. 10 Candela Corporation, a Syneron company (Nasdaq: ELOS), announced today that the SFDA (State Food and Drug Administration) of China has approved the Alex TriVantage® multi-wavelength, Q-switched laser system and the GentleMax® multiple wavelength workstation for sale throughout the People's Republic of China, including Hong Kong. The receipt of the SFDA Certificates will allow Candela to begin the sales process and launch official marketing programs for these products, creating a host of new market opportunities.
Advertisement
The unique Q-switched Laser-Pumped-Laser (LPL) technology of the Alex TriVantage laser provides 755-nm, 532-nm and 1064-nm output wavelengths, making Alex TriVantage extremely versatile. The addition of a long-pulse mode at 755 nm offers advanced treatments for a wider variety of pigmented lesions (many unique to Asian skin) without long-term side effects. Beyond the treatment of benign pigmented lesions and the removal of multi-color tattoo inks, Alex TriVantage enhances the results of many skin rejuvenation treatments, making it an ideal system for optimizing fractional and other rejuvenation treatment results.
Advertisement
By integrating two of aesthetic laser medicine's leading devices, the GentleLASE and GentleYAG, into a configurable, upgradeable workstation, the GentleMax has made treatment for a wider range of patient concerns more readily available. The GentleMax laser system features both 755-nm and 1064-nm wavelengths and may be used to provide permanent hair reduction on all skin types and tanned skin as well as the treatment of vascular and pigmented lesions, wrinkle reduction and skin tightening. With GentleMax, it is now possible for one device to do the work of two or more.
"The Alex TriVantage is our first Q-switched alexandrite laser to be approved in China," said Syneron Chief Executive Officer Louis P. Scafuri. "With its unique Laser-Pumped-Laser (LPL) technology and GentleMax's multiple wavelengths and uses, a greater number of physicians will be able to offer a wider variety of services for conditions with fewer devices. Moreover, this approval enables us to offer a more complete range of highly effective aesthetic solutions in the world's largest market."
For more information on the GentleMax and Alex TriVantage lasers, visit www.candelalaser.com
About Candela
Candela is a wholly-owned subsidiary of Syneron Medical Ltd. (NASDAQ: ELOS), the global leader of aesthetic devices offering the industry's most comprehensive product portfolio and worldwide distribution footprint. The Candela brand supports Syneron's line of aesthetic therapies for the face and body with four decades of industry-leading scientific expertise and innovative aesthetic laser technologies. Syneron distributes and supports its products in 86 countries with offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong. Additional information can be found at www.syneron.com.
SOURCE Candela Corporation
